Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback